Combined application of epigenetic modifiers and TALEs
The patented method enables the reactivation of epigenetically-silenced genes. The scientists have discovered a method for removing methyl groups in certain areas of the DNA, which can be used to reactivate epigenetically-silenced genes. While known transcription factors (proteins that bind to the DNA and switch a gene on via a promoter) like TALEs or zinc fingers already dock at certain gene sections of the DNA, this has not been possible up to now in the case of epigenetically-silenced gene sequences. This problem has now been solved through the addition of valproic acid (VPA 10) and a HDAC inhibitor. This measure made it possible to “open” the packaging of the epigenetically-silenced gene sequences, which consists of HDAC (histone deacetylases), making them accessible to the transcription factors.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…